The following meta‐analysis in four RNA‐seq cohorts of IDH wild‐type GBM showed that TRAF3IP3 might act as a prognostic indicator for IDH wild‐type GBM patients (Figure S3B, Supporting Information). This evidence concerns the gene TRAF3IP3 and glioblastoma.